Clinical Experience With the Addition of Pramlintide in Patients With Insulin-Requiring Type 2 Diabetes

Diabetes Care- United States

doi 10.2337/dc07-0641

Full Text

Abstract

Available in

Date

Authors

Publisher

American Diabetes Association

Related search

Pramlintide in the Management of Insulin-Using Patients With Type 2 and Type 1 Diabetes

Vascular Health and Risk Management
PharmacologyCardiologyEndocrinologyPublic HealthHematologyEnvironmentalCardiovascular MedicineMedicineOccupational HealthMetabolismDiabetes
2006English

Lixisenatide Clinical Experience on Patients With Type 2 Diabetes and Obesity in Endocrinology Offices

Endocrine Abstracts
2015English

15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Drugs in R and D
Pharmacology
2018English

Clinical Variables Associated With Depression in Patients With Type 2 Diabetes

Revista da Associacao Medica Brasileira
Medicine
2015English

Teaching Patients With Type 2 Diabetes to Self-Administer Insulin

Australian journal of general practice
Medicine
2019English

Clinical Study of Treatment Switching From Premixed Insulin to Basal Insulin Combined With Oral Hypoglycemic Drugs in Patients With Type 2 Diabetes

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients

Drugs in Context
Molecular MedicinePharmacology
2019English

Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy